Navigation Links
Mithridion wins grants for Alzheimer's research

Madison, Wis. - Mithridion, Inc., a biopharmaceutical startup that is developing drugs to disrupt the progress of Alzheimer's disease, has secured $296,800 in federal grants to evaluate tests for drug candidates.

The twin grants, awarded by the National Institute on Aging, a branch of th......

Full article >>> the brain that might shield neurons from Amyloid beta, the primary toxin in Alzheimers.

"The advantage of small molecules is that they can be synthesized by chemical means, they can be accurately analyzed, they are relatively low cost for production, and they have a very well-trodden path for getting Food and Drug Administration approval," Twose sa......

Full article >>> > "That's a major advantage and it really stimulates innovation," Twose said. "These grants are really the lifeblood of many, many biotech companies."

......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 08/29/06


Related biology technology :

1. Mithridion raises $1.6M through angel networks
2. Digital Healthcare Conference, Mithridion, lack of degrees
3. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
4. State to offer $850K in high-tech training grants
5. Venture-backed firms could become eligible for federal SBIR grants
6. NASDAQ grants Merge more time for compliance
7. Morgridge seed grants attract over 220 proposals
8. Medical College researchers win federal grants
9. NSF grants bolster integrative graduate study at UW-Madison
10. Three state businesses receive technology grants
11. Visonex plans to expand with state grants, loan
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/22/2017)... , March 22, 2017 Good Start ... it has eclipsed the 130 million covered lives mark ... Shield of Texas . With newly ... Company continues to enjoy strong payor acceptance based on ... clinical programs and genetic counseling, its industry-leading customer care ...
(Date:3/22/2017)... New York , March 22, 2017 ... is largely fragmented, states a research report by Transparency ... S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., accounted ... in 2015. The prominent players in this market are ... expand their product portfolio, which is likely to lead ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced Tallahassee, FL ... live events series, “Stem Cell Therapy: The Next Phase in the Evolution of Medicine.” ... Stem Cell Research and Therapy Act, Okyanos maintains a mission to help “no-option” ...
Breaking Biology Technology:
(Date:3/2/2017)... LONDON , March 2, 2017 Summary ... require to better understand Merck KGaA and its partnering ... report: https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals ... into the partnering activity of one of the world,s ... reports are prepared upon purchase to ensure inclusion of ...
(Date:2/28/2017)... LOS ANGELES , Feb. 28, 2017   ... identity verification software globally, announces significant enhancements to new ... in May 2016. New products include mobile and desktop ... and DocX TM - a real time manual ... Acuant,s core idScan® technology provides the fastest and most ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
Breaking Biology News(10 mins):